AFLAC Incorporated with ticker code (AFL) have now 12 market analysts covering the stock. The analyst consensus now points to a rating of ‘Hold’. The target price High/Low ranges between 80 and 57 suggesting an average Analsyt target price of $70.67. Given that the stocks previous close was at $65.98 this would imply there is now a potential upside of 7.1%. The 50 day moving average now sits at $65.88 and the 200 moving average now moves to $64.95. The company has a market cap of $40,422m. Find out more information at: https://www.aflac.com
The potential market cap would be $43,295m based on the market consensus.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is headquartered in Columbus, Georgia.
The company has a dividend yield of 2.55% with the ex dividend date set at 14-2-2023 (DMY).
Other points of data to note are a P/E ratio of 10.03, revenue per share of 30.72 and a 2.09% return on assets.
